Huami always comes first when it comes to disease prevention. In this regard, we recall the commitment of the Chinese giant in miniaturize the magnetic resonance through its equipment. Or its presence is commendable together with USTC in the field of neuroscience, to help the disabled but not only. Today another interesting collaboration between the company and theGuangzhou Medical University: the two poles have joined together for research against the chronic obstructive pulmonary disease (COPD).
Huami always attentive to health: together with the University of Guanzhou against the chronic obstructive pulmonary disease (COPD)
Huami Technology (from poco Zepp Health), which is deeply involved in the field of health, cloud and smart wearable technology, will provide technical support and equipment for the project as one of the partners. The two main poles, as mentioned, are the wearable company, which has always been Xiaomi's shoulder, and the Guangzhou Medical University. Chronic obstructive pulmonary disease (COPD) is a chronic airway disease and according to data provided by the company, it affects the 13.6% of people aged 40 and over.
Within the j there are also figures that we have already heard like Zhong Nanshan, an engineering academician and PRC medal winner and participant in other research also alongside Huami. But in what will the Chinese wearables company be useful? Most patients do not have tools for early diagnosis and management of this chronic disease. The union of the two poles should recruit approx 2000 subjects with COPD for an observational study that will run for 96 weeks.
Huami's technology will provide subjects with smart wearable devices (specially built) to monitor vital signs. The identified data (steps, heart rate, blood oxygen saturation, etc.). The objective of the joint venture is to produce devices that can prevent early, through precise algorithms, the disease.